Screener
Recursion Pharmaceuticals, Inc. RXRX Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
FAQ
- What is Recursion Pharmaceuticals, Inc.'s price / sales?
- Recursion Pharmaceuticals, Inc. (RXRX) reported price / sales of 35.5× in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s price / sales changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s price / sales increased by 8.1% year-over-year, from 32.8× to 35.5×.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s price / sales?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s price / sales has grown at a -43.9% compound annual growth rate (CAGR), from 287.3× to 28.5×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Recursion Pharmaceuticals, Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude